Effectiveness of Internet-Based Interventions for Treatment Compliance and Outcomes of Major Depressive Disorder
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 440
- Locations
- 1
- Primary Endpoint
- HAMD17 reduction ratio
Study Overview
Brief Summary
The acute and remission depression patients of 18-65 years old were recruited. At the time of enrollment, the demographic, symptomatic, neuropsychological and medication adherence data was collected. After the completion of the baseline assessment and examination, the patients were given antidepressant treatment or antidepressant treatment combined with Internet-based interventions. Clinical evaluation was performed at 1, 3 months (acute patients) and 6, 12 months (remission patients) after treatment, including the medication adherence, therapeutic efficacy, recurrence rate and functional rehabilitation. Through above work, this research is expected to provide clinicians with a set of Internet generalized technologies to improve the compliance and clinical outcomes of patients with depression, and to provide patients with treatment and management of the entire disease cycle.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to 65 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •age 18-65 years old, acute (HAMD17 > 17) and remission (HAMD17 < 8) depression
Exclusion Criteria
- •other mental illnesses, serious somatic illnesses
Arms & Interventions
antidepressant treatment
recieve antidepressant treatment
Intervention: antidepressant treatment (Drug)
antidepressant treatment combined with Internet-based interventions
recieve antidepressant treatment combined with Internet-based interventions
Intervention: antidepressant treatment combined with Internet-based interventions (Other)
Outcomes
Primary Outcomes
HAMD17 reduction ratio
Time Frame: 3 months
The difference of HAMD17 reduction ratio between the two groups was compared
recurrence rate
Time Frame: 12 months
The difference of recurrence rate between the two groups was compared
Secondary Outcomes
No secondary outcomes reported
Investigators
Si Tianmei
Professor
Peking University
